fluorodeoxyglucose f18 has been researched along with Laryngeal Neoplasms in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (12.87) | 18.2507 |
2000's | 37 (36.63) | 29.6817 |
2010's | 43 (42.57) | 24.3611 |
2020's | 8 (7.92) | 2.80 |
Authors | Studies |
---|---|
Beppu, S; Hanai, N; Nishikawa, D; Nishio, M; Sawabe, M; Suzuki, H; Tamaki, T; Terada, H | 1 |
Aro, K; Atula, T; Ilmarinen, T; Markkola, A; Schildt, J; Sistonen, HJ | 1 |
Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
Dhomps, A; Dumollard, JM; Froudarakis, M; Gavid, M; Karpathiou, G; Lelonge, Y; Peoc'h, M; Prades, JM; Prevot-Bitot, N; Vieville, M | 1 |
Al-Mamgani, A; Gouw, ZAR; La Fontaine, MD; Sonke, JJ; van de Kamer, JB; Vogel, WV | 1 |
Annunziata, A; Attanasio, L; Bombace, C; Cuocolo, A; Del Vecchio, S; Mainolfi, CG; Maurea, S; Petretta, M | 1 |
Brown, P; Currie, S; Frood, R; McDermott, G; Nelstrop, H; Prestwich, R; Scarsbrook, AF; Vaidyanathan, S; Zhong, J | 1 |
Amini, A; Eguchi, MM; Goddard, JA; Karam, SD; McDermott, J; Morgan, RL; Mueller, AC; Trivedi, PS | 1 |
Bohr, C; Grosse, J; Hackenberg, B; Hautmann, MG; Jung, EM; Künzel, J; Mehanna, H; Michaelides, I; Rennert, J; Seebauer, CT; Ugele, I | 1 |
Fan, J; Lu, ZJ; Shen, LF; Zhao, K; Zhao, X; Zhou, ML; Zhou, SH | 1 |
Kim, JS; Lee, SW; Park, JW; Song, SY | 1 |
Hamasaki, T; Hanamoto, A; Hatazawa, J; Inohara, H; Isohashi, F; Kishikawa, T; Konishi, K; Michiba, T; Miyabe, J; Nakahara, S; Ogawa, K; Suzuki, M; Takemoto, N; Takenaka, Y; Tatsumi, M; Yoshioka, Y | 1 |
Gattenlöhner, S; Klußmann, JP; Sharma, SJ; Wittekindt, C; Wuerdemann, N | 1 |
Chen, Y; Huang, Z; Qi, C; Xia, Y; Zhang, S | 1 |
Burkill, G; Harries, M; Seymour, N | 1 |
Cermik, TF; Gundogan, C; Karacetin, D; Karagoz, Y; Tatar, G; Yigit, O; Yildiz, E | 1 |
de Bree, R; Hoekstra, OS; Pruim, J; van der Laan, BFAM; van der Putten, L; van Dijk, BAC; Wedman, J | 1 |
Anderson, C; Graham, M; Mallak, N; Mayo, Z; Menda, Y; Mott, SL; Seyedin, SN | 1 |
Broglie, MA; Huber, AM; Huber, GF; Hüllner, MW; Morand, GB; Rupp, NJ; Werner, J | 1 |
Dunne, RM; McDermott, R; O'Keeffe, SA; O'Mahony, D; Wilson, G | 1 |
de Bree, R; Ferlito, A; Rinaldo, A; Takes, RP; Zbären, P | 1 |
Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 2 |
Drescher, R; Freesmeyer, M; Winkens, T | 1 |
Ejima, Y; Kanda, T; Kitajima, K; Kiyota, N; Komatsu, H; Minamikawa, T; Miyawaki, D; Nibu, K; Otsuki, N; Saito, M; Sasaki, R; Suenaga, Y; Sugimura, K; Yoshida, K | 1 |
Cho, JH; Cho, KJ; Chun, BJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Yoo, IeR | 1 |
Inoue, T; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
Ang, KK; Foote, R; Garden, AS; Harari, P; Harris, J; Holland, J; Jones, CU; Le, QT; Levering, A; Opanowski, A; Rosenthal, DI; Schwartz, DL; Trotti, AM; Yao, M; Zhang, Q | 1 |
Ailianou, A; Giger, R; Karamitopoulou, E; Landis, BN; Nisa, L; Salmina, C | 1 |
Boers, M; Comans, EF; de Bree, R; Hobbelink, MG; Hoekstra, OS; Janssen, LM; Leemans, CR; Oyen, WJ; Pruim, J; Takes, RP; Valdés Olmos, R; van den Brekel, MW; van der Laan, BF; van der Putten, L; van Tinteren, H; Wedman, J | 1 |
Itoh, T; Kanda, T; Kitajima, K; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
Amegnizin, JL; Durand, P; Kerrou, K; Ohnona, J | 1 |
Hatanaka, KC; Hirata, K; Kanno-Okada, H; Manabe, O; Mitsuhashi, T; Mizumachi, T; Nakagawa, J; Oyama-Manabe, N; Tamaki, N | 1 |
Aiello, M; Barbuto, L; Cantone, E; Cavaliere, C; Covello, M; Iorio, B; Mesolella, M; Nicolai, E; Romeo, V | 1 |
Caldas-Magalhaes, J; Jager, EA; Kasperts, N; Ligtenberg, H; Pameijer, FA; Philippens, ME; Raaijmakers, CP; Schakel, T; Terhaard, CH; Willems, SM | 1 |
Comans, EF; de Bree, R; Hoekstra, OS; Kuik, DJ; Langendijk, JA; Leemans, CR; van der Putten, L | 1 |
Ahn, SH; Jeon, SY; Kim, CH; Koh, JS; Lee, JC; Lim, SM | 1 |
Fakhry, N; Giovanni, A; Mundler, O; Taïeb, D; Tessonnier, L | 1 |
Brouwer, J; de Bree, R; Hoekstra, OS; Leemans, CR; Uyl-de Groot, CA; van Hooren, AC | 1 |
Aydin, M; Kavak, K | 1 |
Fig, LM; Komissarova, M; Mukherji, SK; Piert, M; Wong, KK | 1 |
Abe, T; Fujita, H; Hayabuchi, N; Ishibashi, M; Kaibara, H; Kaida, H; Kobayashi, M; Kurata, S; Nakashima, T; Tanaka, N; Uchida, M; Uchiyama, Y | 1 |
Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van der Laan, BF | 1 |
Ang, KK; Cannon, BA; Chao, KS; Chronowski, GM; Frank, SJ; Garden, AS; Ginsberg, LE; Lee, JJ; Lippman, SM; Macapinlac, HA; Moeller, BJ; Morrison, WH; Rana, V; Rosenthal, DI; Schwartz, DL; Sturgis, EM; Weber, RS; Williams, MD | 1 |
Dubois, F; Dumollard, JM; Martin, C; Prades, JM; Prevot, N; Richard, C; Timoshenko, AP | 1 |
Chu, MM; Genden, EM; Kao, J; Kositwattanarerk, A; Kostakoglu, L; Lee, DJ; Makkar, JS; Packer, SH; Som, PM | 1 |
Domae, S; Hamaya, K; Hirai, M; Miki, K; Nose, S; Noyama, Y; Orita, Y | 1 |
Abdoli, M; El Naqa, IM; Fuentes, CL; Zaidi, H | 1 |
Abgral, R; Barberot, C; Chinellato, S; Garetier, M; Le Bivic, T; Potard, G; Rousset, J; Salaun, PY; Valette, G | 1 |
Cannon, B; Dong, L; Schwartz, DL | 1 |
Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Geiger, B; Heusner, TA; Lehnerdt, G; Mattheis, S; Treffert, J | 1 |
Chen, TY; Chiu, JS; Hung, CC; Hung, GU; Kao, CH | 1 |
Chopra, A; De Noronha, R; Ford, A; Matthews, S | 1 |
Dai, BL; Ling, L; Luo, XM; Luo, YZ; Wang, QY; Yan, SX; Zhao, K; Zhou, SH | 1 |
Choi, SH; Kim, JS; Kim, SY; Nam, SY; Park, GC; Roh, JL | 1 |
Banks, KP; Clemenshaw, MN; Craun, JB; Moren, RW | 1 |
Li, H; Lv, Y; Tian, Y; Wang, Q; Wu, H; Zheng, H; Zhou, W | 1 |
Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
Chen, HH; Chen, IH; Fan, KH; Huang, SF; Kang, CJ; Liao, CT; Lin, CY; Wang, HM; Yen, TC | 1 |
Bongers, V; Hobbelink, MG; Hordijk, GJ; van Rijk, PP | 1 |
Kao, CH; Shen, YY | 1 |
Dietz, A; Dollner, R; Harms, W; Henze, M; Jungehülsing, M; Rudat, V | 1 |
Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ; Vaalburg, W; van der Laan, BF | 1 |
Daisne, JF; Geets, X; Gregoire, V; Hamoir, M; Lonneux, M | 1 |
Daisne, JF; Duprez, T; Grégoire, V; Hamoir, M; Lonneux, M; Reychler, H; Weynand, B | 1 |
Conessa, C; Foehrenbach, H; Hervé, S; Poncet, JL | 1 |
Mackie, GC; Yarram, SG | 1 |
Lee, M; Lilien, DL; Nathan, CO; Ramaswamy, MR | 1 |
Arens, A; de Jong, J; Kremer, B; Lambin, P; Thimister, P; van Baardwijk, A; Verseput, G | 1 |
Bar-Shalom, R; Daitzchman, M; Doweck, I; Golz, A; Gordin, A; Israel, O; Keidar, Z; Kuten, A; Yefremov, N | 1 |
Alvarez Pérez, RM; Borrego Dorado, I; Ceballo Pedraja, JM; Esteban Ortega, F; Ruiz Franco-Baux, J; Vázquez Albertino, R | 1 |
Huang, WS; Milan, PP; Shih, WJ | 1 |
Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, S; Nam, SY; Pae, KH; Roh, JL | 1 |
Hayashi, T; Higashiyama, S; Kawabe, J; Kawamura, E; Kotani, J; Kurooka, H; Kusuki, M; Oe, A; Shiomi, S; Torii, K; Tsumoto, C; Tsushima, H; Yamane, H | 1 |
Chang, CY; Cherng, SC; Huang, WS; Lin, LF; Lin, YS; Peng, YJ | 1 |
Coche, E; Cosnard, G; Duprez, T; Geets, X; Grégoire, V; Lee, JA; Lonneux, M; Tomsej, M | 1 |
Allard, M; Ducassou, D; Fernandez, P; Guyot, M; Lazaro, E; Viallard, JF | 1 |
Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
Brouwer, J; Castelijns, JA; de Bree, R; Hoekstra, OS; Hooft, L; Leemans, CR; Riphagen, II | 1 |
Akarriou, M; Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Langendijk, JA; Leemans, CR | 1 |
Friedrich, G; Gugatschka, M; Schwarz, T | 1 |
Austin, JR; Kim, EE; Wong, FC | 1 |
Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
Cappellari, JO; Frazier, LC; Geisinger, KR; Greven, KM; Harkness, BA; Keyes, JW; McGuirt, WF; Raben, M; Watson, NE; Williams, DW | 1 |
Bailet, J; Chaiken, L; Choi, Y; Hanafee, WN; Hoh, CK; Jabour, BA; Lufkin, RB; Maddahi, J; Rege, SD; Soong, JC | 1 |
Anzai, Y; Bradford, CR; Carroll, WR; Minoshima, S; Quint, DJ; Wahl, RL; Wolf, GT | 1 |
Greven, KM; Keyes, JW; McGuirt, WF; Watson, N; Williams, DW | 1 |
Hordijk, GJ; Mertens, IJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
Boyd, J; Dunphy, F; Kim, HJ; Lowe, V | 1 |
Hordijk, GJ; Stokkel, MP; Terhaard, CH; van Rijk, PP | 1 |
Boyd, JH; Dunphy, FR; Eisenbeis, JF; Fletcher, JW; Kim, H; Lowe, VJ | 1 |
Birzgalis, AR; Collins, CD; Cowan, RA; Farrington, WT; Hastings, DL; Johnson, RJ; Slevin, NJ; Swindell, R; Waller, ML | 1 |
Hoekstra, A; Stokkel, MP; van Rijk, PP | 1 |
Allal, A; Bang, P; Becker, M; Dulguerov, P; Guyot, JP; Haenggeli, CA; Lehmann, W; Slosman, D | 1 |
Chou, C; Cui, R; Yen, TC; Zhu, Z | 1 |
Courtois, A; De Dreuille, O; Foehrenbach, H; Gaillard, JF; Garcia, D; Kossowski, M; Maszelin, P; Merlet, P; Poncet, JL | 1 |
Bongers, V; Hordijk, GJ; Terhaard, CH; van Rijk, PP | 1 |
Conessa, C; Foehrenbach, H; Gaillard, JF; Kossowski, M; Maszelin, P; Poncet, JL | 1 |
Dietz, A; Eisenhut, M; Haberkorn, U; Henze, M; Mier, W; Mohammed, A; Nollert, J; Rudat, V | 1 |
5 review(s) available for fluorodeoxyglucose f18 and Laryngeal Neoplasms
Article | Year |
---|---|
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma-a review.
Topics: Biopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Larynx; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Warthin's tumor of the larynx: a very rare case and systematic review of the literature.
Topics: Adenolymphoma; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngoscopy; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma, B-Cell, Marginal Zone; Prednisone; Radionuclide Imaging; Treatment Outcome; Vincristine | 2012 |
Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.
Topics: Carcinoma, Squamous Cell; Confidence Intervals; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Probability; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
6 trial(s) available for fluorodeoxyglucose f18 and Laryngeal Neoplasms
Article | Year |
---|---|
Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Larynx; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Salvage Therapy; Treatment Outcome | 2016 |
2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
Topics: Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity | 2008 |
[Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Salvage Therapy; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Topics: alpha-Methyltyrosine; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Iodine Radioisotopes; Laryngeal Neoplasms; Male; Middle Aged; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2002 |
90 other study(ies) available for fluorodeoxyglucose f18 and Laryngeal Neoplasms
Article | Year |
---|---|
Total lesion glycolysis as a predictor of clinical T3-4a laryngeal cancer with laryngectomy or nonlaryngectomy.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
Topics: Carcinoma; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Correlation Between Semiquantitative Metabolic Parameters After PET/CT and Histologic Prognostic Factors in Laryngeal and Pharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Topics: Aged; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Middle Aged; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Squamous Cell Carcinoma of Head and Neck | 2020 |
FDG-PET/CT imaging during the Covid-19 emergency: a southern Italian perspective.
Topics: Betacoronavirus; Carcinoma; Coronavirus Infections; COVID-19; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Italy; Laryngeal Neoplasms; Pandemics; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Procedures and Techniques Utilization; Radiopharmaceuticals; Retrospective Studies; SARS-CoV-2; Thymoma | 2020 |
Machine learning-based FDG PET-CT radiomics for outcome prediction in larynx and hypopharynx squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Hypopharynx; Laryngeal Neoplasms; Machine Learning; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2021 |
Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.
Topics: Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Medicare; Middle Aged; Mouth; Neoplasm Recurrence, Local; Oropharynx; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck; United States | 2021 |
In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
Topics: Animals; Cell Line, Tumor; Cell Survival; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Laryngeal Neoplasms; Mice; Mice, Nude; Oligonucleotides, Antisense; Positron Emission Tomography Computed Tomography; Radiation Dosage; Radiation-Sensitizing Agents; Radiotherapy; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
Prediction of local control in early glottic carcinoma using the maximum standardised uptake value.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach.
Topics: Adult; Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Survival Analysis; Treatment Outcome; Tumor Burden | 2017 |
[Fibrinous lesions of the larynx in a 34-year old patient].
Topics: Adult; Biopsy; Diagnosis, Differential; Dysphonia; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Mucosa; Laryngeal Neoplasms; Laryngitis; Laryngoscopy; Lymphocytosis; Lymphoma, Extranodal NK-T-Cell; Paranasal Sinus Neoplasms; Positron Emission Tomography Computed Tomography; Ulcer | 2017 |
Elevated 18F-NaF uptake in cricoid cartilage in a patient with laryngeal carcinoma: A case report and literature review.
Topics: Carcinoma, Squamous Cell; Cricoid Cartilage; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2017 |
An analysis of true- and false-positive results of vocal fold uptake in positron emission tomography-computed tomography imaging.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vocal Cords; Young Adult | 2018 |
The value of whole-body contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of patients with laryngeal carcinoma.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2018 |
Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
Topics: Aged; Carcinoma; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Clinical Utility of Pretreatment and 3-Month
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv
Topics: Aged; Biomarkers; Combined Modality Therapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; ROC Curve | 2019 |
The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Mammography; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms; Ultrasonography, Mammary | 2013 |
Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Neck; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2014 |
Utility of 18F-FDG PET/CT in supracricoid partial laryngectomy.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Avoidance of false-positive findings on ¹⁸F-FDG-PET/CT using PET/ultrasound fusion: displaced laryngeal silicone implant versus recurrent cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Migration; Humans; Laryngeal Neoplasms; Lung Neoplasms; Positron-Emission Tomography; Prostheses and Implants; Radiography; Radiopharmaceuticals; Silicones; Ultrasonography | 2014 |
Prognostic value of FDG PET imaging in patients with laryngeal cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2014 |
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT).
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Therapeutics; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
Topics: Adult; Aged; Blood Glucose; Chemoradiotherapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Second Primary; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections.
Topics: Buttocks; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Granuloma; Head and Neck Neoplasms; Humans; Incidental Findings; Injections, Intramuscular; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Squamous Cell Carcinoma of Head and Neck; Transgender Persons | 2016 |
MRI and 18F-FDG PET/CT of Laryngeal Cartilaginous Tumor.
Topics: Bone Neoplasms; Cartilage; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Hypopharynx; Imaging, Three-Dimensional; Laryngeal Neoplasms; Laryngectomy; Larynx; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2017 |
Esophageal and laryngeal cancer incidentally found on [18F]fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
False-positive finding on FDG-PET/CT after injectable elastomere implant (Vox implant) for vocal cord paralysis.
Topics: Dimethylpolysiloxanes; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx, Artificial; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Silicone Elastomers; Tomography, X-Ray Computed; Vocal Cord Paralysis | 2008 |
The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
Topics: Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Unusual urethral F18-FDG accumulation on PET/CT.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed; Urethra | 2009 |
Spectrum of 18F-FDG PET/CT findings in oncology-related recurrent laryngeal nerve palsy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vocal Cord Paralysis | 2009 |
The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2009 |
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multivariate Analysis; Pharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Risk Assessment; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Oropharyngeal Neoplasms; Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Image Enhancement; Laryngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Neuroendocrine carcinoma of the larynx presenting as a primary unknown carcinoma.
Topics: Aged, 80 and over; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography | 2012 |
Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Laryngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tumor Burden | 2012 |
Early recurrence or submucosal residual of laryngeal squamous cell carcinoma: diagnosis by CT-guided endolaryngeal core biopsy on a transcutaneous approach.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Metabolic imaging biomarkers of postradiotherapy xerostomia.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Organs at Risk; Oropharyngeal Neoplasms; Parotid Gland; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Xerostomia | 2012 |
Virtual 3-D ¹⁸F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients: a feasibility study.
Topics: Aged; Aged, 80 and over; Endoscopy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Pharyngeal Neoplasms; Positron-Emission Tomography; Respiratory System; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; User-Computer Interface | 2012 |
Asymptomatic metastasis to the larynx detected by FDG PET/CT in a patient with recurrent rectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Rectal Neoplasms; Recurrence; Tomography, X-Ray Computed | 2012 |
Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer.
Topics: Adult; Aged; Cohort Studies; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Parotid Neoplasms; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed | 2013 |
Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Sarcoidosis; Thorax; Tomography, X-Ray Computed | 2012 |
[Value of (18)F-FDG PET/CT in the diagnosis of laryngeal carcinoma].
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Serpins | 2013 |
Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Misdiagnosis of laryngeal cancer resulting from FDG secretion in saliva.
Topics: Adult; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Radiopharmaceuticals; Saliva; Tomography, Emission-Computed | 2003 |
18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Dideoxynucleosides; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Larynx; Male; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Topics: Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Methionine; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Laryngeal Neoplasms; Laryngectomy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Pleomorphic adenoma simulating metastatic squamous cell carcinoma on f-18 fluorodeoxyglucose positron emission tomography.
Topics: Adenoma, Pleomorphic; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Unilateral vocal cord paralysis causes contralateral false-positive positron emission tomography scans of the larynx.
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Muscles; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Vocal Cord Paralysis | 2005 |
False-positive FDG-PET scan due to brown tumours.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Laryngeal Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
F-18 FDG PET demonstrates crossed cerebellar diaschisis 20 years after stroke.
Topics: Aged; Brain Ischemia; Cerebellar Diseases; Cerebellum; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Longitudinal Studies; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stroke; Time Factors | 2006 |
2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Salvage Therapy; Survival Rate; Treatment Outcome | 2007 |
Detection of local residual tumor after laryngeal cancer treatment using FDG-PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Retrospective Studies | 2007 |
Laryngeal giant cell tumor mimicking thyroid cancer demonstrated by PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Laryngeal Neoplasms; Leydig Cell Tumor; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, Spiral Computed | 2007 |
Systemic tuberculosis presenting as an epiglottic mass detected on F-18 FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Epiglottis; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tuberculosis | 2007 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Positron emission tomography/computed tomography as a method for detection and monitoring of laryngeal chondritis.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cartilage Diseases; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Positron emission tomography in the detection of residual laryngeal carcinoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxyglucose; Edema; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Laryngeal Diseases; Laryngeal Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiotherapy Dosage; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Neck; Neoplasm Staging; Pharyngeal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Topics: Deoxyglucose; Diagnosis, Differential; Edema; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1994 |
Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.
Topics: Contrast Media; Deoxyglucose; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Neck; Nose; Orbit; Parotid Neoplasms; Pharynx; Tomography, Emission-Computed; Tongue Neoplasms | 1993 |
Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
Topics: Aged; Aged, 80 and over; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Laryngeal radionecrosis versus recurrent cancer: a clinical approach.
Topics: Algorithms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prospective Studies; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1998 |
Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
Topics: Aged; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1998 |
The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed | 1999 |
Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Topics: Carcinoma in Situ; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cords | 1999 |
The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nose Neoplasms; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tonsillar Neoplasms | 1999 |
The detection of small carcinoma with 18F-FDG using a dual head coincidence camera.
Topics: Adult; Aged; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
[Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Oropharyngeal Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
Elevated F-18 FDG uptake in laryngeal muscles mimicking thyroid cancer metastases.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Muscles; Laryngeal Neoplasms; Male; Neoplasm Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
[Positron emission tomography in head and neck oncology: five cases].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Positron emission tomography in head and neck oncology].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, Emission-Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2001 |